fda compounding semaglutide enforcement news november 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these GLP-1 Weight Loss Drug Enforcement

Researchers need identity review, analytical documentation, fill accuracy, vial presentation, storage awareness, packaging quality, and a supplier that handles fulfillment directly

That means that a big open question is whether the side effect profiles may differ in subgroups of people that scientists have not directly studied, which include a large swath of people now taking these drugs to lose only about 10 to 15 pounds

Brand-name Wegovy cash-pay runs $199-$349/mo, pushing total out-of-pocket to ~$494/mo without insurance well above the cheapest tirzepatide online self-pay options

Retatrutide adds glucagon signaling, shifting physiology further toward output and fuel utilization, which may increase reward blunting in some lab subjects

Retatrutides molecular structure allows for detailed studies into how multiple pathways work together to affect metabolism and energy balance

Truist analyst Jailendra Singh said employers are directly driving cash-pay activity, through benefit guides and by advertising platforms like TrumpRx and manufacturer pharmacies